Not Held. That says all I need to know about your intentions in...

First 144 Last

Share
Profile

Follow
Jasventure

1,165 Posts.

115

27/07/18

12:27

Post #: 34593060
Share

Originally posted by El Jefe ↑

You are nose to nose with "big brother" when the facts are the company stated production from March. Are you really boasting about that like its good thing? Your ramp up phase should be close to complete if timelines were met but your staring down the barrel of another 6 months to get to that point.

Im not stirring up any panic, the underperformance of the company your invested in does that. If timelines were met we wouldn't even be discussing another CR and the company would be close to nameplate and in a strong position to implement Stage 2 expansions. Another poster expects a ~4% dilution which is fine he may be right but id be guessing ~10% (at 25-27c) because the last thing they want to do is have to go back to market a second time and its obvious based on an earlier post today that construction and production is not yet going to plan based on where the spodumene is being produced from, unless you will tell me next they built the big conveyors and pad just for the heck of it (which wouldn't surprise me).

I am quoting production costs figures from a broker are you suggesting you are a better analyst than the CG guys? They cant get it 100% right but I think they can give a better estimate than you and I.

I haven't looked at valuation/prices at all but The estimates are not calendar years they are FYs predictions so CG are accurate to say zero for the FY just passed. If you have an issue with them you should be able to find there number online somewhere and ask them about there character, just dont do it with a mouthful of beer you might ruin the screen on your computer.

Expand

Not Held. That says all I need to know about your intentions in our forum.

AJM Price at posting: 30.0¢ Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

FFM

Firefly positioned for copper growth in Canada ahead of resource update

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

CC9

Chariot Corp unveils plans for Black Mountain "pilot mine" in Wyoming, US; shares jump +20%

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

There are more pages in this discussion • 41 more messages in this thread...

First 144 Last

Add 1MC (ASX) to my watchlist

(20min delay)
Last 3.1¢		Change 0.000(0.00%)		Mkt cap ! $8.394M

Open	High	Low	Value	Volume
3.1¢	3.1¢	2.8¢	$1.89K	65.23K

Buyers (Bids)

No.	Vol.	Price($)
4	228475	2.8¢

Sellers (Offers)

Price($)	Vol.	No.
3.1¢	275572	4

View Market Depth

No.	Vol.	Price($)
4	228475	0.028
1	61938	0.027
1	111148	0.026
4	165000	0.025
1	25000	0.024

Price($)	Vol.	No.
0.031	275572	4
0.032	92168	2
0.033	378549	3
0.034	270000	1
0.035	200000	1

Last trade - 15.43pm 03/10/2024 (20 minute delay)

1MC (ASX) Chart

Not Held. That says all I need to know about your intentions in...

Firefly positioned for copper growth in Canada ahead of resource update

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Chariot Corp unveils plans for Black Mountain "pilot mine" in Wyoming, US; shares jump +20%

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Not Held. That says all I need to know about your intentions in...

Top Stories

Firefly positioned for copper growth in Canada ahead of resource update

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Chariot Corp unveils plans for Black Mountain "pilot mine" in Wyoming, US; shares jump +20%

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News